Temperature Detection Screen Market Rising Demand in Global Market Growth by 2030 | FLIR Systems Inc., Leonardo S.p.A., L3Harris Technologies Inc., Axis Communications AB, Opgal, OptoTherm Inc., Thermoteknix Systems Ltd., Fluke Corporation, Seek Thermal Inc., 3M Company,

The global market for temperature detection screens is currently valued at US$ 1.2 billion and is anticipated to reach US$ 4.2 billion by the end of 2030, growing at a startling CAGR of 16.9% from 2022 to 2030.

Global Temperature Detection Screen Market Size (2022) US$ 1.2 Bn
Estimated Market Revenue (2030) US$ 4.2 Bn
Forecasted Market Growth Rate (2022-2030) 16.9% CAGR
Healthcare Industry Market Share 24%

The demand for temperature detection screens and sensors increased significantly in 2020 as a result of the COVID-19 epidemic. 15% of the worldwide thermal sensing market is now occupied by sales of temperature detection screens.

Request a report sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-11297

Key Market Dynamics

One of the primary diagnostic technologies used in industrial applications, thermal imaging technology is continually being explored. In the manufacturing sector, such temperature detection screens are essential for spotting flaws and irregularities that are otherwise undetectable to the naked eye. The market for temperature detection screens may experience expansion as a result of these advantages.

Additionally, the combination of sophisticated robotics and automation tools with temperature monitoring screens and thermal imaging apparatus aids in the discovery of anomaly hotspots and the formulation of the maintenance strategy. The advantages of using temperature detection screens and related equipment have been recognised by numerous industries throughout the world, which is fueling the expansion of the temperature detection screen market.

Key Takeaways of Temperature Detection Screen Market Study

  • Temperature detection screen market in Europe is expected to hold leading revenue by the end of the forecast period.
  • The healthcare, and government and law enforcement industries are estimated to be primary end users in the global temperature detection screen market.
  • Portable/handheld temperature detection screens are likely to register a higher adoption rate compared to their fixed/mounted variants.
  • Infrared thermal scanning cameras are highly expensive and are estimated to witness a lower rate of adoption as compared to contactless temperature detectors.

COVID-19 Pandemic Impact Analysis

The healthcare industry is witnessing considerable upsurge in demand for contactless thermal scanners and temperature detectors. Such temperature detective screens are playing a crucial role on a global scale amidst the ongoing COVID-19 pandemic. The non-contact temperature screening feature helps screen patients while enabling healthcare professional and authorities avoid the contagion.

As the number of COVID-19 infections continues to grow, the healthcare industry is focusing on procuring medical tools and equipment to monitor and contain the spread of COVID-19 virus. This demand for thermal scanners and temperature detection screens is increasing rapidly on a global level.

Request Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-11297

Key Segments of Temperature Detection Screen Industry Survey

Temperature Detection Screen Market by Product:

  • Infrared Thermal Scanning Cameras
  • Contactless Temperature Detectors

Temperature Detection Screen Market by Type:

  • Portable/Handheld Temperature Detection Screens
  • Fixed/Mounted Temperature Detection Screens

Temperature Detection Screen Market by End Use:

  • Temperature Detection Screens for Government and Law Enforcement
  • Temperature Detection Screens for Military and Defence
  • Temperature Detection Screens for Transportation and Logistics
  • Temperature Detection Screens for Commercial Spaces
  • Others

Temperature Detection Screen Market by Region:

  • North America Temperature Detection Screen Market
  • Latin America Temperature Detection Screen Market
  • South Asia & Pacific Temperature Detection Screen Market
  • Middle East & Africa (MEA) Temperature Detection Screen Market

Request advisory customization available@
https://www.futuremarketinsights.com/customization-available/rep-gb-11297

More Valuable Insights on Temperature Detection Screen Market

Future Market Insights offers an unbiased analysis of the global temperature detection screen market, providing historical data for 2015-2021 and forecast statistics from 2022-2030. To understand opportunities in the temperature detection screen market, the market is segmented on the basis of product, type, and end-use across six major regions.

Read Related Reports:

https://medium.com/@akshay.shinde.vu/power-electronics-market-size-2022-statistics-share-price-growth-prospects-industry-trends-ca026f13efb3
https://medium.com/@akshay.shinde.vu/koninklijke-philips-nv-apple-inc-7ead4fcad60c
https://medium.com/@akshay.shinde.vu/market-share-demand-analysis-growth-trends-and-forecast-for-visitor-management-systems-through-12e029607cf7
https://medium.com/@akshay.shinde.vu/latest-trends-regional-perspectives-and-global-industry-dynamics-for-the-marine-communication-3ae98dfcf11f

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/temperature-detection-screen-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Organoids Market Key Players : Hubrecht Organoid Technology (HUB), OcellO B.V., Cellesce Ltd, DefiniGEN, Qgel

Organoids are three-dimensional (3D) structures that resemble mammalian organs and are made from stem cells. As per a study by Future Market Insights (FMI), the global organoids market is estimated to reachUS$ 44.2 Mn in 2021.

As new platforms for quicker drug development and improved model structures for assessing drug efficacy and toxicity, organoids have the potential to be transformative. Traditional drug discovery approaches are less important and inadequate to keep up with the rapid pace of life science advancements. Organoids are projected to exhibit increasing sales within the drug discovery industry.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8106

The demand for cutting-edge preclinical testing methods has increased as a result of advances in drug therapies such as personalized treatments and expanding medical research to identify new advance medicines.Organoids also are used to shortlist possible drug molecules and remove the remainder by considering ‘in-vitro’ conditions that are somewhat close to natural environmental conditions.

According to the International Federation of Pharmaceutical Manufacturers and Societies, preclinical research accounts for about 22% of the overall cost of drug production. The use of organoids in drug development shortens the process and saves money, resulting in a greater demand for organoids.

In terms of product, intestinal organoids are expected to register high demand, accounting for over 36% of sales in the market. While application of organoids is expected to be considerably high in bio banking.

Key Takeaways from Organoids Market Study

  • The organoids market will exhibit solid growth, registering above 14% CAGR between 2021 and 2031
  • The expansion of pharmaceutical sector and investment in research initiatives will enable the U.S. account for over 95% sales in North America
  • The U.K. will emerge as the leading market, exhibiting above 20% y-o-y growth in 2021
  • Germany and France are expected to emerge as other lucrative markets within the U.K.
  • China will remain a leading market for organoids in East Asia, however, the Japan market will register a slightly higher rate of growth

“Capability of 3D-organoid cultures to mimic organ functionality as well as increasing adoption of the organoid technology for use in a range of applications, including genetic mutation and other is expected to drive the growth of Organoids market” says the FMI Analyst

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8106

Funding for life science research and investments in Organoids products to expand various projects and personnel employedis the major factor expected to boost the organoids market growth.

For instance, the total amount of research grants awarded by the National Institutes of Health (NIH) in the U.S. exceeded US$ $251 million over five years (2015 to 2019).

Key players in the Organoids are Entering into Strategic Alliance

The top players are focusing on expanding their business footprint through acquisitions. Acquisitions provide the company with strong foot hold of new products, buyer suppliers relationship, and new geographic horizons to tap the market potential. The key manufacturers aretargeting towardsacquiring well-known products and technologies that are expected to have a successful revenue stream. This also helps the business to grow into new emerging markets while also developing existing ones.

For instance, in September 2020,a Memorandum of Understanding (MoU) was signed by BGI-Qingdao and Ubrecht Organoid Technology (HUB) to develop a joint Next Generation Diagnostics (NGD) centre in China to improve personalised care, better treatments and cures, and faster development of new safe medicines.HUB and BGI will combine their complementary skills and technologies to further improve and incorporate HUB Organoid Technology as predictive diagnostic tests, allowing for reliable patient-specific treatment response prediction, initially with a focus on cancer.

As a result of increased emphasis on oncological research and increased R&D spending, the global organoids market is expected to expand over the forecast period. Organoids market is highly competitive exhibiting the presence of several players. Because of the high capital investment required to build an Organoids manufacturing facility, pharmaceutical companies are increasingly looking to outsource the process.The key market players covered by FMI include STEMCELL Technologies Inc., Cellesce Ltd., DefiniGEN, Qgel, Hubrecht Organoid Technology, OcellO B.V.consolidating their positions through mergers, acquisitions and new product launches.

For in-depth competitive analysis Buy Now@ https://www.futuremarketinsights.com/checkout/8106

Valuable Insights into Organoids Market

Future Market Insights, in its new offering, provides an unbiased analysis of the organoids market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the market based on product type (intestinal organoids, hepatic organoids, pancreatic organoids, colorectal organoids, and neural organoids), application (bio-banking, biomedical research and drug discovery, regenerative medicines, cancer research, and therapeutic tools), and end user (biopharmaceutical companies, contract research organizations, and academics and research institutes) across seven major regions.

Organoids Market by Category By Product Type, Organoids market is segmented as:

  • Intestinal Organoids
  • Hepatic Organoids
  • Pancreatic Organoids
  • Colorectal Organoids
  • Neural Organoids
  • Others

By Application, Organoids market is segmented as:

  • Bio-banking
  • Biomedical Research and Drug Discovery
  • Regenerative Medicine
  • Cancer Research
  • Therapeutic Tools
  • Others

By End User, Organoids market is segmented as:

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Academics and Research Institutes

By Region, Organoids market is segmented as:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Contraceptive Market size reaching US$ 30.8 Billion by 2032

[200 Pages Report] In 2022, the global contraceptives market is expected to be worth US$ 18 billion. Contraceptive drug and device demand is expected to grow at a 5.5 percent CAGR, with the total market size reaching US$ 30.8 billion by 2032. According to a recent study by Future Market Insights (FMI), devices will lead the market in terms of product, accounting for approximately 58.3 percent of the market in 2021.

The global contraceptives market size is expected to reach ~US$ 33,529 Mn by the end of 2029. According to a study by Future Market Insights (FMI), the market will show a steady rise at a CAGR of ~6.2% between 2019 and 2029. According to the report, growing need of population control, increasing incidence of unwanted pregnancies and government’s initiatives drive the contraceptive market forward. It uses unique research methods to offer the most accurate analysis of the market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1091

It includes in-depth insights into the contraceptives market. Some of these are:

  • The estimated value of the contraceptives market was at ~US$ 33,529 Mn in 2019. Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.
  • Regionally, North America dominates the contraceptives market globally.
  • East Asia emerges as one of key markets owing to large population base, growing contraceptive awareness and initiatives taken by the respective country government.
  • Female segment holds the most of the contraceptive market as compared to men.
  • Key players are likely to focus on new product development in terms of drug & device, to stay relevant in developed markets.

Contraceptive Pills – the Most Lucrative Product Type

Contraceptive market contains drugs and devices. The devices market holds most the contraceptive market however drugs are anticipated to grow at highest CAGR owing to its beneficial property and easy consuming method. With the advancement of technology, the emergence of drugs have become popular as oral contraceptive pills which has the same purpose as other contraceptive drugs or devices. The simplicity and easy consumable method are expected to make it most popular contraceptive market. The other form of drugs such as topical and injectable contraceptives also witness strong market demand. Furthermore, these contraceptive pills are highly effective and does not interrupt in sex. Even in cases, it has been proved to reduce heavy and painful periods. All these factors and benefits are expected to fuel the sales of contraceptive drugs in the global market.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1091

Some of the leading players operating in the contraceptives market are Bayer AGPfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer, The Female Health Company and others. As a result of increasing competition, companies are focusing on expanding their product portfolio with new innovation. In addition to this, mergers and acquisition remains a popular strategy among market players. Companies intend to expand their regional footprint through strategic collaborations.

  • As a part of government’s initiative, the government of India had launched a new contraceptive pill named ‘Shukhi 3rd Generation’ in Nov 2019.
  • In Spet. 2019, Exeltis USA, Inc. had announced the Launch of Slynd™(drospirenone) tablets, the First and only progestin-only pill providing pregnancy prevention with a 24-hour missed pill window

Get Valuable Insights into Contraceptives Market

Future Market Insights, in its new report, presents an unbiased analysis of the global Contraceptives market, covering historical demand data and forecast figures for the period between 2019 and 2029. The study divulges compelling insights on the contraceptives market based on product type (contraceptive drugs – oral contraceptive pills, injectable, topical), gender (male, female), by price range (high range, low /economy), sales channel (Wholesaler/ Distributor, Hypermarket/ Supermarket, Specialty Stores, Drug & Pharma Stores, Convenience Stores, online, and others -hospitals, clinics etc.), region (North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa).

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1091

Market segmentation

Product Type

  • Contraceptive Drugs
    • Oral Contraceptive Pills
    • Injectables
    • Topical
  • Contraceptive Devices
    • Diaphgrams
    • Sponges
    • Vaginal Rings
    • Subdermal Implants
    • Intrauterine Device
    • Condom

Gender

  • Male
  • Female

Price Range

  • High Range
  • Low / Economy Range

Sales Channel

  • Wholesaler/ Distributor
  • Hypermarket/ Supermarket
  • Specialty Stores
  • Drug & Pharma Stores
  • Convenience Stores
  • Online
  • Others (hospitals, clinics etc.)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Obesity Management Market is projected to reach US$ 1.3 Billion by 2031

Globally, more than 1 billion individuals are overweight or obese and the numbers continue rising. This high prevalence of obesity will drive demand for obesity management products and services in the long term.

According to the World Health Organization (WHO), approximately 1.9 billion adults were overweight and 650 million adults were obese. Whereas 38.3 million children under 5 years of age were either overweight or obese in 2019. One in three adults in North America is obese. In the U.S., 80 million adults and 12.7 million children suffer from obesity.

Obesity is a prominent community health problem in many parts of the world. It is associated with numerous health disorders including gallbladder disease, heart disease, diabetes, stroke, hypertension, and fatty liver disease in addition to some cancers. According to a recent Future Market Insights (FMI) report, the market is set to surpass US$ 1.2 Bn by the end of the forecast period in 2031, with a CAGR of over 5%.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-587

Furthermore, there has been an increase in the per capita healthcare expenditure, especially in developed countries, with better reimbursement policies. People are now inclined towards out-of-pocket expenditure healthcare. Personal health, grooming, and concerns over social discrimination are leading people to take obesity management consultations.

However, the unprecedented pandemic crisis has had a significant impact on the obesity management market due to a slump of patient footfall in hospitals and clinics. Preference is now being given to the treatment of COVID-19 patients, limiting resources for anti-obesity consultations and related drugs or surgeries.

Also, there has been a halt in clinical trials for weight management drugs. However, with the availability and commencement of the COVID-19 vaccination, the clinical trials are resuming and are anticipated to pick up pace during the forecast period. Also, the adoption of telehealth and in developing countries is likely to bode well for the future of the market in the long term.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-587

Key Takeaways from Obesity Management Market Study

  • Bupropion and Naltrexone will reflect register faster growth at a CAGR of 8.4%, owing to an increase in the preference for combination therapy in weight management.
  • Gastric sleeve surgery will account for over 40% of the market throughout the forecast period owing to benefits of simplicity and time-efficiency.
  • The U.S. will lead the North America market with a share of over 64% in 2021, driven by continuing diet and lifestyle issues prevalent in the country.
  • Germany followed by Russia are leading markets in Europe, reflecting CAGR of over 6% through the end of 2031, driven by improvements in public health programs.
  • Japan dominates the East Asia market, accounting for 49% value share in 2021, with government awareness programs contributing to growth.

“The rapidly increasing obesity cases and the resultant chronic diseases have triggered concern among patients and healthcare professionals. The COVI-19 crisis has alarmed people, as overweight people are at higher risk of acquiring SARS-COV2. This consciousness may help in encouraging obesity management uptake through 2021 and beyond,” says the FMI analyst.

Key Participant Insights

Prominent players in the Obesity Management Market are focusing on collaborations, mergers & acquisitions for global expansion and enhanced opportunities focused on emerging economies thereby, enhancing their market presence.

The key market players covered by FMI include GlaxoSmithKline Plc., VIVUS, Inc., Novo Nordisk A/S, Currax Pharmaceuticals LLC, Cheplapharm Arzneimittel GmbH, Bausch Health Companies Inc., and Takeda Pharmaceuticals, Inc.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-587

Obesity Management Market by Category

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Injectable Benzodiazepine Market to grow at 2.7% CAGR through 2030

Global injectable benzodiazepine sales are set to reach USD 260 million in 2020, as covid-19 panic and uncertainty has set in, even among population with no previous history of mental illnesses, according to a new study by Future Market Insights (FMI). The market research firm estimates the market to grow at 2.7% CAGR through 2030.

Although covid-19 will create a short-term spike, in the long run, the market is likely to be driven by increasing demand for generic drugs. Growing acceptance of injectables as a route of administration is also likely to drive growth.

Key Takeaways of Injectable Benzodiazepine Market Study

  • Lorazepam injectable benzodiazepine accounted for the highest share in the injectable benzodiazepine market in 2019
  • Seizures and anxiety among leading ailments where injectable benzodiazepines are administered
  • North America and Europe are expected to hold a noteworthy revenue share of about 60% in the global injectable benzodiazepine market in 2020

Low cost manufacturing and large patient pools in Asian countries expected to be a key growth driver in the forecast period

“Growing incidences of seizures and anxiety followed by demand for generics to boost the global injectable benzodiazepine market,” says an FMI Analyst.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-11724

Research Collaborations: Key to SustenanceThe market players are emphasizing on expanding their manufacturing facilities with introduction of cost-effective and generic drugs and also venturing into strategic partnerships.

  • In Jan 2020, Hospital Sales Force from Xellia signed an agreement with Eton to promote Biorphen in the institutions that prefer having ready-to-use injectable formulations
  • In Oct 2019, KemPharm’s APADAZ (to treat ADHD) got licensed to KVK-Tech, Inc. to make its generic AG-APADAZ available all across the US
  • In Dec 2018, Hikma Pharmaceuticals came up with clobazam oral suspension as well as tablets, the generic equivalent to “Onfi” (marketed by H. Lundbeck A/S)

What else is in the report?Future market insights offer a unique perspective and actionable insights on injectable benzodiazepine market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on drug class (diazepam, lorazepam, and midazolam), by time of action (short acting long acting), by indication (agitation & aggression, anxiety, alcohol withdrawal, muscle spasm, seizures, tetanus, sedation, anesthesia insomnia, and status epilepticus), by distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) in seven key regions.

Key Segments of Injectable benzodiazepines MarketFMI’s study on the injectable benzodiazepines market offers information divided into three important segments— drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

  • Diazepam
  • Lorazepam
  • Midazolam

Time of Action

  • Short Acting
  • Long Acting

Indication

  • Agitation & Aggression
  • Anxiety
  • Alcohol Withdrawal
  • Muscle Spasm
  • Seizures
  • Tetanus
  • Sedation
  • Anaesthesia
  • Insomnia
  • Status Epilepticus

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-11724

Distribution Channel

  • Hospital
  • Ambulatory Surgical centers
  • Diagnostics Centers

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Canine Atopic Dermatitis Treatment Market will surpass US$ 2.4 Billion in 2029

Industry leaders must forge strategic alliances with regional players to reinforce their global presence and variegate product offerings for sustained competitive ascendancy in canine atopic dermatitis treatment market.

Global revenue s of canine atopic dermatitis treatment market will surpass US$ 2.4 Bn in 2029. The growth in market value will be staggering, accredited to advancements in biotechnology, gene therapy, digital innovations, and increased investments from market players, as indicated by a new FMI report.

“Sales of canine atopic dermatitis treatment drugs and vaccines will continue to surge at an impressive rate owing to innovations in novel drug development in veterinary science. In view of enhanced resistance towards certain therapeutic agents, the demand for immune-specific vaccines and drugs is witnessing an upswing,” says the FMI analyst.

Request sample of this report at https://www.futuremarketinsights.com/reports/sample/rep-gb-4412

Key Takeaways of Canine Atopic Dermatitis Treatment Market Study

  • Immunosuppressant drugs that currently lead the market will lose their market share to monoclonal antibodies (mAb).
  • Oral administration remains at the forefront of preferred drug intake method.
  • Injectable drugs will witness a steady CAGR and will rise to prominence by 2029, surpassing oral administration.
  • Retail pharmacies continue to hold the leading revenue share; veterinary clinics closing in.
  • Gains in canine atopic dermatitis treatment market are concentrated in North America.

Top Growth Drivers

  • Established players in human life sciences are investing significant pecuniary resources in veterinary science, ascertaining the market growth.
  • Robust healthcare infrastructure and rising pet ownership are bolstering the growth of market in North America.
  • Swift recovery and less side effects remain the growth levers fueling demand for injectable veterinary drugs.
  • Increasing online availability and easy accessibility of medical information will continue to be the significant growth contributor.

Key Restraints

  • Certain therapeutic agents are facing increasing resistance, which is limiting the demand for immunosuppressant drugs.
  • Ineffectual management by healthcare providers is a major hindrance to market growth.

Schedule a meeting with expert analysts for detailed insights https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4412

Competitive Landscape

Leading players in global canine atopic dermatitis treatment market include, but are not limited to, Elanco Animal Health, Zoetis, Boragen Inc., and Immunomic Therapeutics Inc. Industry giants are focused on strategic alliances with regional players to boost their global presence. They continue to direct substantial resources towards regional acquisitions in order to fortify their market foothold. For instance, Zoetis acquired Nexvet Biopharma (2018) to accelerate the development of mAb therapies. This would enable the company to create new alternatives for treating canine atopic dermatitis. On the other hand, Elanco Animal Health acquired Boehringer Ingelheim Vetmedica, Inc. (2017), to innovate their range of rabies vaccines, canine and feline products.

More About the Report

This 213-page study offers an in-depth market forecast and analysis on canine atopic dermatitis treatment market. The major categories encompassed by the report include drug class (monoclonal antibodies, antipruritics, essential fatty acids, emollients, antihistamines, antibiotics, immunosuppressants and corticosteroids), mode of administration (injectable, oral and topical), distribution channel (mail order pharmacies, drug stores, retail pharmacies, veterinary clinics and veterinary hospitals) across seven regions (Oceania, East Asia, South Asia, Latin America, North America, Middle East & Africa and Europe).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

U.S. Animal Model Market is anticipated to increase at a high CAGR of 4.1 % (2022-2032)

As per Future Market Insights’ latest industry analysis, the U.S. animal model market was valued at over US$ 921.9 Mn in 2021 and is anticipated to exhibit a CAGR of close to 4.1% over the forecast period (2022-2032).

Animal models are predominantly used to gather information regarding the disease and its prevention, diagnosis, and treatment. They are being used to resolve a wide range of scientific concerns, ranging from basic science to the discovery and evaluation of new vaccines and therapies. Animals are used because of the similarities in biology across most mammals.

Get Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14527

Personalized medicine is also known as precision medicine which utilizes data about a specific patient or an individual’s genes to plan treatment for a disease. Animal models can play important role in the development of new approaches for personalized medicine. Increasing adoption of personalized medicine will drive sales of animal model in the forthcoming years.

Toxicity testing in animals is done to discover potential side effects from an agent’s exposure and to generate dose-response relationships. Animal testing is important for the early detection of the potential risk to humans or as models to study the causes, pathogenesis, progression, and treatment of diseases.

Organizations and legislations such as the Federal Food, Drug, and Cosmetic Act (FFDCA), Environmental Protection Agency (EPA), Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and Organization for Economic Co-operation and Development (OECD) determine the testing guidelines for toxicity testing on animals.

Some factors such as the high production volume of chemicals testing in the U.S., increasing generation and utilization of novel GM animal strains in toxicity studies, and the development and attempted validation of several animal tests to screen chemicals for endocrine (hormone)-disrupting activity are expected to drive the growth in the market.

Key Takeaways:

  • Based on species, the mice model segment is expected to hold nearly 62.6% of the total market share 2022, with sales growing at a 5.1% CAGR.
  • In terms of therapeutics, the oncology accounted for more than 32.0% of the total market share in 2021, and the trend is expected to continue over the forecast period.
  • By application, sales in the drug discovery/development segment commanded 65.4% of the total market share in 2021.
  • Based on end user, the academic & research institutes segment accounted 36.6% of the total market share in 2021.

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14527

Key Players:

  • Charles River Laboratories
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • Genoway
  • Envigo (Inotiv, Inc.)
  • Marshall BioResources
  • Janvier Labs
  • Applied stem cells
  • Biocytogen
  • Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
  • Cyagen
  • Ingenious targeting labs
  • Crown Bioscience Inc. (JSR Corporation).
  • Harbour Biomed
  • Sinclair Bio Resources
  • Alpha Genesis Inc.
  • Creative Animodel
  • DaVinci Biomedical Research Products, Inc

Market Competition

Key players operating in the U.S. animal model market are expanding their business through partnerships and acquisitions with other companies to improve their global footprint. Following are a few examples of acquisitions:

  • In October 2021, The Jackson Laboratory completed the acquisition of Charles River Laboratories Japan’s Research Models & Services (RMS), which allows advancement in the company’s scientific improvements in basic research and drug discovery.
  • In November 2021, Inotiv, Inc., which is a leading contract research organization (CRO) completed its acquisition of Envigo RMS Holding Corp. to expand its R&D sector.
  • In February 2021, Biocytogen completed the acquisition of a third Beacon Optofluidic system. This acquisition expanded Biocytogen’s service platform in the Boston area.

For in-depth competitive analysis, Buy Now @ https://www.futuremarketinsights.com/checkout/14527

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the animal model market in its latest study, presenting a historical demand assessment of 2017–2021 and projections for 2022– 2032.

The research study is based on the species – (rats, mice, pigs, rabbits, monkeys, dogs, cats, other species), therapeutics- (metabolic diseases, cardiovascular diseases, neurological diseases, and oncology), application (drug discovery/development and basic & applied research) end-user (academic & research institutes, pharmaceutical companies, biotechnology companies, and CROs) and across seven key regions of the world.

Future Market Insights’ Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Proteinase K Market is projected to reach US$ 33.4 Million by the end of 2026

Proteinase K is a million dollar market accounting for a small portion in reagents and enzymes. Proteinase K is mainly used in contract research organisations, biotechnology companies, academic institutes, and diagnostics laboratories. In terms of revenue, the global Proteinase K market is expected to reach US$ 33.4 Mn by the end of 2026, witnessing a CAGR of 6.1%.

A plethora of factors are expected to impact the growth of the global Proteinase K market. A significant rise in research and development activities, lesser production costs, broader application of Proteinase K and good product stability and specificity of Proteinase K will give a massive push to the revenue growth of the global Proteinase K market by the end of the forecast period. A steady rise of chronic diseases and better government backed investment channels to fund advanced research and development are expected to boost the expansion of the global Proteinase K market over the period of assessment. An increasing number of research activities, soaring expenditure on personal healthcare and increasing adoption of gene therapy has been significantly high in the U.S. market in the recent years, making North America the most lucrative regional market for Proteinase K.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2399

Global Proteinase K Market: Segmental Forecast

  • By form, the lyophilized powder form segment is anticipated to account for higher revenue share in the global Proteinase K as compared to the liquid form segment. Lyophilized powder from segment is expected to reach a market value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.3% over the forecast period. The growth in lyophilized powder form can be attributed to the increasing advantages of powder form over liquid form in case of storage and preservation of samples.
  • By application, purification of DNA & RNA segment will account for the highest revenue share in the global Proteinase K market as compared to other applications of Proteinase K. Purification of DNA & RNA segment is expected to reach a value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.5% over the forecast period.
  • By end user, the biotechnology companies segment is expected to project higher demand for Proteinase K as compared to other end user segments such as academic institutes and diagnostics laboratories. The strong growth in biotechnology companies can be attributed to an increasing use of Proteinase K in research and development and new drug discovery. The cost effectiveness of Proteinase K over other reagents is the key factor responsible for its increasing use in biotechnology companies. The biotechnology companies segment is expected to register the highest CAGR of 6.7% over the forecast period.

Global Proteinase K Market: Regional Market Projections

Demand for research in academics and funding facilities provided by the U.S government to support gene therapy and other activities for drug development is anticipated to boost the North America Proteinase K market. Followed by North America, Western Europe and APEJ are the most lucrative regions in the global Proteinase K market and are anticipated to grow by 5.7% and 6.1% respectively over the forecast period. Increasing demand for drug development, rising hereditary diseases due to changing lifestyles and growing disposable income are some of the factors expected to contribute to the growth of the global Proteinase K market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2399

Global Proteinase K Market: Vendor Insights

Top companies profiled in the global Proteinase K market report include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Worthington Biochemical Corporation, Sisco Research Laboratories Pvt. Ltd, Promega Corporation, Bioline and F. Hoffmann-La Roche AG among others. Leading market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Merck KGaA acquired Sigma-Aldrich to strengthen and expand its consumable and reagent portfolio.

Market Segmentation Form

  • Lyophilized Powder Form
  • Liquid Form

Application

  • Isolation and purification of genomic DNA & RNA
  • In Situ Hybridization
  • Mitochondria isolation
  • Enzyme Removal

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Connected Logistics Market Share, Demand Analysis, Growth, Trends and Forecast – 2029

The market for linked logistics is expected to grow from its current value of US$ 22.2 billion in 2022 to US$ 47.6 billion by the end of 2029. Over the projection period, demand for connected logistics is anticipated to grow at an excellent CAGR of 11.5%. (2022-2029).

Connected Logistics Market Size (2022) US$ 22.2 Bn
Predicted Net Worth (2029) US$ 47.6 Bn
Global Market Growth Rate (2022-2029) 11.5% CAGR
Roadways Market Share 41.4%

The majority of freighting operations, which make up a significant portion of logistics and supply chains, are conducted on roads, which dominate the connected logistics sector. Currently, 10% of the revenue generated by the global supply chain management business comes from connected logistics.

“Logistics industry is incorporating technologies such as Artificial Intelligence to manage inventory and reduce operational costs. Moreover, key players utilize this technology to manage networks, optimize delivery routes and to predict demand. Artificial Intelligence has helped streamline the entire logistics ecosystem,” concludes the FMI report.

Key Takeaways of Connected Logistics Market Study

  • While software segment will be in high demand, devices continue to be preferred by consumers across the globe.
  • Roadways will continue to be the preferred mode of transportation through 2029.
  • Retail & consumers industry remains the key end-use area of connected logistics market.
  • North America remains lucrative connected logistics market in view of ongoing digitization process.

Connected Logistics Market – Key Growth Factors

  • Increasing adoption in manufacturing sector is supporting the growth of connected logistics market.
  • Technological advancements in logistics industry such as blockchain technology and Internet of Things are bolstering the market growth.
  • Preponderance of digital sales channels continues to shape the connected logistics market.
  • Rapid tech penetration in Asia Pacific is boosting the regional connected logistics market.
  • Need for real-time data and tracking precise location is pushing the growth of connected logistics market.

Connected Logistics Market – Key Restraints

  • Dynamic competitive structure of connected logistics market presents critical challenges for market leaders.
  • Data security issues associated with cloud-based technologies is limiting the growth of connected logistics market.

Request TOC @
https://www.futuremarketinsights.com/customization-available/rep-gb-4287

Competitive Landscape

Global connected logistics market is fragmented in nature. Prominent stakeholders profiled in this FMI study include, but are not limited to, Cisco, Infosys Ltd., Intel Corporation, IBM Corporation, SAP SE, and Bosch. Off-highway Vehicle (OHV) and Radio-frequency Identification (RFID) continue to be prioritized by market players. Moreover, enhanced customer retention, personnel safety and better stock are key focus areas of industry leaders. Software component will offer lucrative growth opportunities for key players through the forecast period.
Key Segments of Connected Logistics Industry Survey

Connected Logistics Market by Component:

  • Connected Logistics Devices
    • Vehicle Telematics
    • Data Loggers
    • GPS Tracking Devices
    • RFID Tags
  • Connected Logistics Software
    • Fleet Management
    • Asset Tracking
    • Security Solutions
  • Connected Logistics Services
    • Consulting
    • Integration & Deployment
    • Support & Maintenance

Connected Logistics Market by Transportation:

  • Connected Logistics for Roadways
  • Connected Logistics for Railways
  • Connected Logistics for Airways
  • Connected Logistics for Seaways

Connected Logistics Market by Vertical:

  • Connected Logistics in Manufacturing
  • Connected Logistics in IT & Telecom
  • Connected Logistics in Automotive
  • Connected Logistics in Retail & Consumer Goods
  • Connected Logistics in Food & Beverages
  • Connected Logistics in Healthcare
  • Connected Logistics in Energy & Utilities
  • Others

Connected Logistics Market by Region:

  • North America Connected Logistics Market
  • Latin America Connected Logistics Market
  • Europe Connected Logistics Market
  • East Asia Connected Logistics Market
  • South Asia & Pacific Connected Logistics Market
  • Middle East & Africa (MEA) Connected Logistics Market

Request Advisory customization available@
https://www.futuremarketinsights.com/customization-available/rep-gb-4287

More about the Report

This Future Market Insights study of 388 pages provides all-inclusive insights on the global connected logistics market. The market analysis is based on component (devices, software, and services), transportation (roadways, railways, airways, and seaways), and vertical (manufacturing, IT & telecom, automotive, retail & consumer goods, food & beverages, healthcare, energy & utilities) across six regions (North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa).

Read Related Reports:

https://medium.com/@akshay.shinde.vu/power-electronics-market-size-2022-statistics-share-price-growth-prospects-industry-trends-ca026f13efb3
https://medium.com/@akshay.shinde.vu/koninklijke-philips-nv-apple-inc-7ead4fcad60c
https://medium.com/@akshay.shinde.vu/market-share-demand-analysis-growth-trends-and-forecast-for-visitor-management-systems-through-12e029607cf7
https://medium.com/@akshay.shinde.vu/latest-trends-regional-perspectives-and-global-industry-dynamics-for-the-marine-communication-3ae98dfcf11f

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/connected-logistics-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Ophthalmic Lasers Market is projected to increase from a valuation of US$ 884.3 Million in 2022

[294 Pages Report] Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market is no exception. Over the years, ophthalmic disorders such as diabetic retinopathy, refractive errors, glaucoma, cataract and age related macular degeneration (AMD) have surged exponentially. This has accelerated demand for advanced surgical procedures.

The introduction of ophthalmic laser surgery has revolutionized ophthalmic care in unprecedented ways. Majority of these technologies are being deployed in cataract surgeries, attributed to the disorder’s widespread prevalence across all continents. Advancements such femtosecond laser surgeries have proven highly instrumental in streamlining ophthalmic procedures, offering lightning speed detection of faulty tissues.

Such reduced detection and treatment timeframes act as major growth catalysts for the global ophthalmic lasers market, which is anticipated to reach a value of US$ 1.3 Bn by 2030.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1529

Market Outlook:

Data Points Market Insights
market Value 2021 USD 838.4 Mn
market Value 2022 USD 884.3 Mn
market Value 2030 USD 1.3 Bn
CAGR 2022-2030 5.4%
Share of Top 5 Countries 60.4%
Key Players The key players in ophthalmic lasers market are Abbott Medical Optics, Inc., Alcon Inc. (Novartis AG), Bausch & Lomb Incorporated, LENSAR, LLC, NIDEK CO., LTD, iVIS Technologies, ZEISS International, Ziemer Ophthalmic Systems AG, and SCHWIND eye-tech-solutions GmbH & Co. KG.

Ophthalmic Lasers Market- Key Highlights

  • Ophthalmic lasers market shall expand steadily at a CAGR of 5.4% from 2022-2030
  • Cataract surgeries shall account for the majority share of the global ophthalmic lasers market
  • Femtosecond laser surgery to hold maximum sway throughout the forecast period
  • North America shall retain market hegemony, owing to increasing regulatory approvals for laser surgeries by authorities
  • Asia & Europe to contribute nearly identical revenue shares due to rise in surgeries amidst their geriatric population

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1529

COVID-19 Impact Analysis

The novel coronavirus pandemic will have a significantly high impact on the ophthalmic lasers market. As lockdowns and curbs continue to remain enforced, the number of footfalls across ophthalmology clinics and hospitals have declined considerably. Patient care has diminished by nearly 60%, with only emergency surgeries being permitted.

With in-patient visits becoming next to impossible, ophthalmologists are resorting to telemedicine with regards to consultation and advice to patients. A slump is anticipated in refractive and premium lens surgeries across developing economies in the long-run, attributed to cash crunches experienced by individual households due to the prolonged lockdowns.

At the same time, several countries are enforcing strict social distancing protocols and hygiene practices, keeping demand for ophthalmic laser surgeries sustained. For instance, ophthalmologists in Germany have made it a protocol to test patients requiring intravitreal injections and other procedures for COVID-19. If positive, they are redirected to emergency departments, reducing chances of infection.

“Vendors in the ophthalmic lasers landscape are striving to introduce novel product lines, equipped with multi-frequency selection modes to reduce exposure to intense laser bursts, preventing healthy tissue damage,” infers the FMI analyst.

Competition Dashboard

Prominent vendors in the ophthalmic lasers market include are ZEISS International, Nidek Inc., Bausch & Lomb Inc., Abbot Laboratories Inc., SCHWIND Eye-Tech Solutions, Ziemer Ophthalmic Systems AG, Novartis AG (Alcon), LENSAR LLC., iVIS Technologies and NKT Photonics A/S. New product launches and collaborations have helped these players acquire firm footing.

In 2018, ZEISS International rolled out its VISUFIT 1000 digital 3D centration data determination and consultation platform, offering a three-dimensional facial reconstruction which enables ophthalmologists perform precise centration processes on patients.

In July 2022, SCHWIND Eye-Tech acquired CE approval for its SCHWIND ATOS femtosecond laser, permitting eye surgeons to incorporate the technology in their SmartSight refractive surgery procedures.

More Insights on the Ophthalmic Lasers Market

A recent market study published by FMI on the ophthalmic lasers market includes the global industry analysis of 2014-2021 & opportunity assessment for 2022-2030, and delivers a comprehensive assessment of the most important market dynamics. The report provides a balanced, unbiased analysis of the overall market scenario based on product type (excimer lasers and femtosecond lasers), application (refractive surgery, cataract surgery, capsulotomy, trabeculoplasty and diagnostics), end-user (hospitals, ophthalmology clinics and ambulatory surgical centers) and region (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1529

Ophthalmic lasers market by Category

By Product :

  • Excimer Lasers
  • Femtosecond Laser

By Application :

  • Refractive Surgery
  • Cataract Surgery
  • Posterior Capsulotomy
  • Trabeculoplasty
  • Diagnostic

By End user :

  • Hospital
    • 500 Bedded+
    • 250-499 Bedded
    • Less than 250
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs